TY - JOUR
T1 - The NLRP1 inflammasome
T2 - new mechanistic insights and unresolved mysteries
AU - Mitchell, Patrick S.
AU - Sandstrom, Andrew
AU - Vance, Russell E.
N1 - Funding Information:
We thank Dan Bachovchin (MSKCC) and members of the Vance and Barton labs for helpful input. R.E.V. is an HHMI Investigator and is supported by N.I.H. AI075039 and AI063302 ; P.S.M. is supported by a Jane Coffin Childs Memorial Fund for Medical Research postdoctoral fellowship.
Publisher Copyright:
© 2019 Elsevier Ltd
PY - 2019/10
Y1 - 2019/10
N2 - Nucleotide-binding domain, leucine-rich repeat (NLR)proteins constitute a diverse class of innate immune sensors that detect pathogens or stress-associated stimuli in plants and animals. Some NLRs are activated upon direct binding to pathogen-derived ligands. In contrast, we focus here on a vertebrate NLR called NLRP1 that responds to the enzymatic activities of pathogen effectors. We discuss a newly proposed ‘functional degradation’ mechanism that explains activation and assembly of NLRP1 into an oligomeric complex called an inflammasome. We also discuss how NLRP1 is activated by non-pathogen-associated triggers such as the anti-cancer drug Val-boroPro, or by human disease-associated mutations. Finally, we discuss how research on NLRP1 has led to additional biological insights, including the unexpected discovery of a new CARD8 inflammasome.
AB - Nucleotide-binding domain, leucine-rich repeat (NLR)proteins constitute a diverse class of innate immune sensors that detect pathogens or stress-associated stimuli in plants and animals. Some NLRs are activated upon direct binding to pathogen-derived ligands. In contrast, we focus here on a vertebrate NLR called NLRP1 that responds to the enzymatic activities of pathogen effectors. We discuss a newly proposed ‘functional degradation’ mechanism that explains activation and assembly of NLRP1 into an oligomeric complex called an inflammasome. We also discuss how NLRP1 is activated by non-pathogen-associated triggers such as the anti-cancer drug Val-boroPro, or by human disease-associated mutations. Finally, we discuss how research on NLRP1 has led to additional biological insights, including the unexpected discovery of a new CARD8 inflammasome.
UR - http://www.scopus.com/inward/record.url?scp=85065795719&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065795719&partnerID=8YFLogxK
U2 - 10.1016/j.coi.2019.04.015
DO - 10.1016/j.coi.2019.04.015
M3 - Review article
C2 - 31121538
AN - SCOPUS:85065795719
SN - 0952-7915
VL - 60
SP - 37
EP - 45
JO - Current Opinion in Immunology
JF - Current Opinion in Immunology
ER -